M. Cevik, M. Tate, O. Lloyd, A. E. Maraolo, J. Schafers, and A. Ho, "SARS-CoV-2, SARS-CoV, and MERS-CoV viral load dynamics, duration of viral shedding, and infectiousness: a systematic review and meta-analysis," (in eng), Lancet Microbe, vol. 2, no. 1, pp. e13-e22, Jan 2021, doi: https://doi.org/10.1016/s2666-5247(20)30172-5.
M. C. Kim et al., “Duration of Culturable SARS-CoV-2 in hospitalized patients with Covid-19," (in eng), N Engl J Med, Jan 27 2021, doi: https://doi.org/10.1056/NEJMc2027040.
World Health. Criteria for releasing COVID-19 patients from isolation: scientific brief, 17 June 2020, vol. 2020. Geneva: World Health Organization; 2020. issue CC BY-NC-SA 3.0 IGO. [Online]. Available: https://apps.who.int/iris/handle/10665/332451. Accessed 31 May 2021
Q. X. Long, X.J. Tang, Q.L. Shi, Q. Li, H.J. Deng, J. Yuan, J.L. Hu, W. Xu, Y. Zhang, F.J. Lv, K. Su, F. Zhang, J. Gong, B. Wu, X.M. Liu, J.J. Li, J.F. Qiu, J. Chen, A.L. Huang, "Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections," (in eng), Nat Med, vol. 26, no. 8, pp. 1200–1204, Aug 2020, doi: https://doi.org/10.1038/s41591-020-0965-6.
C. Jiang, Y. Wang, M. Hu, L. Wen, C. Wen, Y. Wang, W. Zhu, S. Tai, Z. Jiang, K. Xiao, N. R. Faria, E. de Clercq, J. Xu, G. Li, "Antibody seroconversion in asymptomatic and symptomatic patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)," (in eng), Clin Transl Immunol, vol. 9, no. 9, p. e1182, 2020, doi: https://doi.org/10.1002/cti2.1182.
T. Shirin, T. R. Bhuiyan, R. C. Charles, S. Amin, I. Bhuiyan, Z. Kawser, A. Rahat, A. N. Alam, S. Sultana, M. A. Aleem, M. H. Khan, S. R. Khan, R. C. LaRocque, S. B. Calderwood, E. T. Ryan, D. M. Slater, S. Banu, J. Clemens, J. B. Harris, M. S. Flora, F. Qadri, "Antibody responses after COVID-19 infection in patients who are mildly symptomatic or asymptomatic in Bangladesh," (in eng), Int J Infect Dis, vol. 101, pp. 220–225, Dec 2020, doi: https://doi.org/10.1016/j.ijid.2020.09.1484.
T. Aydillo et al., "Shedding of viable SARS-CoV-2 after immunosuppressive therapy for cancer," (in eng), N Engl J Med, vol. 383, no. 26, pp. 2586–2588, Dec 24 2020, doi: https://doi.org/10.1056/NEJMc2031670.
J. H. Baang et al., "Prolonged Severe Acute Respiratory Syndrome Coronavirus 2 Replication in an Immunocompromised Patient," (in eng), J Infect Dis, vol. 223, no. 1, pp. 23–27, Jan 4 2021, doi: https://doi.org/10.1093/infdis/jiaa666.
V. A. Avanzato et al., "Case Study: Prolonged Infectious SARS-CoV-2 Shedding from an Asymptomatic Immunocompromised Individual with Cancer," (in eng), Cell, vol. 183, no. 7, pp. 1901–1912.e9, Dec 23 2020, doi: https://doi.org/10.1016/j.cell.2020.10.049.
J. He et al., "Circulating precursor CCR7(lo)PD-1(hi) CXCR5+ CD4+ T cells indicate Tfh cell activity and promote antibody responses upon antigen reexposure," (in eng), Immunity, vol. 39, no. 4, pp. 770–781, Oct 17 2013, doi: https://doi.org/10.1016/j.immuni.2013.09.007.
A. Busch, D. Zeh, V. Janzen, L.O. Mügge, D. Wolf, L. Fingerhut, C. Hahn-Ast, O. Maurer, P. Brossart, M. von Lilienfeld-Toal, "Treatment with lenalidomide induces immunoactivating and counter-regulatory immunosuppressive changes in myeloma patients," (in eng), Clin Exp Immunol, vol. 177, no. 2, pp. 439–453, Aug 2014, doi: https://doi.org/10.1111/cei.12343.
I. Thevarajan, T. H. O. Nguyen, M. Koutsakos, J. Druce, L. Caly, C. E. van de Sandt, X. Jia, S. Nicholson, M. Catton, B. Cowie, S. Y. C. Tong, S. R. Lewin, K. Kedzierska, "Breadth of concomitant immune responses prior to patient recovery: a case report of non-severe COVID-19," (in eng), Nat Med, vol. 26, no. 4, pp. 453–455, Apr 2020, doi: https://doi.org/10.1038/s41591-020-0819-2.
L. Hansmann, L. Blum, C. H. Ju, M. Liedtke, W. H. Robinson, and M. M. Davis, "Mass cytometry analysis shows that a novel memory phenotype B cell is expanded in multiple myeloma," (in eng), Cancer Immunol Res, vol. 3, no. 6, pp. 650–660, Jun 2015, doi: https://doi.org/10.1158/2326-6066.Cir-14-0236-t.
T. Rasmussen, L. Jensen, and H. E. Johnsen, "The clonal hierachy in multiple myeloma," (in eng), Acta Oncol, vol. 39, no. 7, pp. 765–770, 2000, doi: https://doi.org/10.1080/028418600750063479.